Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Ri-qiang Liao"'
Autor:
Si-Yang Liu, Song Dong, Xue-Ning Yang, Ri-Qiang Liao, Ben-Yuan Jiang, Qun Wang, Xiao-Song Ben, Gui-Bin Qiao, Jun-Tao Lin, Hong-Hong Yan, Li-Xu Yan, Qiang Nie, Hai-Yan Tu, Bin-Chao Wang, Jin-Ji Yang, Qing Zhou, Hong-Rui Li, Ke Liu, Wendy Wu, Si-Yang Maggie Liu, Wen-Zhao Zhong, Yi-Long Wu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-10 (2023)
Abstract This prospective multicenter phase II study evaluated the clinical efficacy of neoadjuvant nivolumab-exclusive (N) and nivolumab–chemotherapy (N/C) combinations based on PD-L1 expression. Eligible patients exhibited resectable clinical sta
Externí odkaz:
https://doaj.org/article/fac0f07d3dc04d809e388bf7352818af
Autor:
Wen-Zhao Zhong, Hong-Hong Yan, Ke-Neng Chen, Chun Chen, Chun-Dong Gu, Jun Wang, Xue-Ning Yang, Wei-Min Mao, Qun Wang, Gui-Bin Qiao, Ying Cheng, Lin Xu, Chang-Li Wang, Ming-Wei Chen, Xiao-Zheng Kang, Wan-Pu Yan, Ri-Qiang Liao, Jin-Ji Yang, Xu-Chao Zhang, Si-Yang Liu, Qing Zhou, Yi-Long Wu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-8 (2023)
Abstract EMERGING-CTONG 1103 showed improved progression-free survival (PFS) with neoadjuvant erlotinib vs. chemotherapy for patients harbouring EGFR sensibility mutations and R0 resected stage IIIA-N2 non-small cell lung cancer (NSCLC) (NCT01407822)
Externí odkaz:
https://doaj.org/article/1f184cb431924c6cb798d962d9892a83
Autor:
Ri-qiang Liao, An-wei Li, Hong-hong Yan, Jun-tao Lin, Si-yang Liu, Jing-wen Wang, Jian-sheng Fang, Hong-bo Liu, Yong-he Hou, Chao Song, Hui-fang Yang, Bin Li, Ben-yuan Jiang, Song Dong, Qiang Nie, Wen-zhao Zhong, Yi-long Wu, Xue-ning Yang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundEstimating the growth of pulmonary sub-solid nodules (SSNs) is crucial to the successful management of them during follow-up periods. The purpose of this study is to (1) investigate the measurement sensitivity of diameter, volume, and mass
Externí odkaz:
https://doaj.org/article/75f8ac0969224488b65fbafd6ea25706
Autor:
Yu-Min Zhong, Kai Yin, Yu Chen, Zhi Xie, Zhi-Yi Lv, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Bin-Chao Wang, Wen-Zhao Zhong, Ling-Ling Gao, Wen-Bin Zhou, Ji Chen, Hai-Yan Tu, Ri-Qiang Liao, Dong-Kun Zhang, Shui-Lian Zhang, Dan-Xia Lu, Hong-Bo Zheng, Heng-Hui Zhang, Yi-Long Wu, Xu-Chao Zhang
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Primary pulmonary lymphoepithelioma-like carcinoma (PLELC) is an Epstein–Barr virus (EBV)-related, rare subtype of non-small-cell lung cancer (NSCLC). Immune checkpoint inhibitors (ICI) show durable responses in advanced NSCLC. However, their effec
Externí odkaz:
https://doaj.org/article/3962ac96e92147ac8deafa74f0ed1910
Autor:
Jia-Tao Zhang, Hao Qin, Fiona Ka Man Cheung, Jian Su, Da-Dong Zhang, Shi-Yi Liu, Xiao-Fang Li, Jing Qin, Jun-Tao Lin, Ben-Yuan Jiang, Song Dong, Ri-Qiang Liao, Nie Qiang, Xue-Ning Yang, Hai-Yan Tu, Qing Zhou, Jin-Ji Yang, Xu-Chao Zhang, Ya-Nan Zhang, Yi-Long Wu, Wen-Zhao Zhong
Publikováno v:
Journal of Extracellular Vesicles, Vol 8, Iss 1 (2019)
In this study, we evaluated the diagnostic value and molecular characteristics of plasma extracellular vesicles (EVs)-derived miRNAs for patients with solitary pulmonary nodules (SPNs), particularly ground-glass nodules (GGNs). This study was registe
Externí odkaz:
https://doaj.org/article/3f69e13fb26f48fcb5282387bc75f415
Autor:
Hao-Ran Zhai, Xue-Ning Yang, Qiang Nie, Ri-Qiang Liao, Song Dong, Wei Li, Ben-Yuan Jiang, Jin-Ji Yang, Qing Zhou, Hai-Yan Tu, Xu-Chao Zhang, Yi-Long Wu, Wen-Zhao Zhong
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-10 (2017)
Abstract Background Right upper lobectomy (RUL) for lung cancer with different dissecting orders involves the most variable anatomical structures, but no studies have analyzed its effects on postoperative recovery. This study compared the conventiona
Externí odkaz:
https://doaj.org/article/08034e7db62941e6bd6ff26fbacb31c1
Autor:
Yi-Long Wu, Xue-Ning Yang, Wen-Zhao Zhong, Qing Zhou, Xin Yi, Xuefeng Xia, Hai-Yan Tu, Jin-Ji Yang, Xu-Chao Zhang, Pingping Dai, Yanfang Guan, Song Dong, Ri-Qiang Liao, Qiang Nie, Ben-Yuan Jiang, Kai Yin, Jun-Tao Lin, Hong-Lian Lu, Yuhua Gong, Yu Chen, Liyan Ji, Hong-Hong Yan, Si-Yang Maggie Liu, Wei Gao, Si-Yang Liu, Jia-Tao Zhang
The efficacy and potential limitations of molecular residual disease (MRD) detection urgently need to be fully elucidated in a larger population of non–small cell lung cancer (NSCLC). We enrolled 261 patients with stages I to III NSCLC who underwen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::461884d03027c757cd60458ddc0ea360
https://doi.org/10.1158/2159-8290.c.6549524.v1
https://doi.org/10.1158/2159-8290.c.6549524.v1
Autor:
Yi-Long Wu, Xue-Ning Yang, Wen-Zhao Zhong, Qing Zhou, Xin Yi, Xuefeng Xia, Hai-Yan Tu, Jin-Ji Yang, Xu-Chao Zhang, Pingping Dai, Yanfang Guan, Song Dong, Ri-Qiang Liao, Qiang Nie, Ben-Yuan Jiang, Kai Yin, Jun-Tao Lin, Hong-Lian Lu, Yuhua Gong, Yu Chen, Liyan Ji, Hong-Hong Yan, Si-Yang Maggie Liu, Wei Gao, Si-Yang Liu, Jia-Tao Zhang
Supplementary Data from Longitudinal Undetectable Molecular Residual Disease Defines Potentially Cured Population in Localized Non–Small Cell Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27cafd19c276d03ffa0b7f06433603c7
https://doi.org/10.1158/2159-8290.22540964.v1
https://doi.org/10.1158/2159-8290.22540964.v1
Autor:
Yi-Long Wu, Tony S. Mok, Ri-Qiang Liao, Qiang Nie, Wen-Zhao Zhong, Xue-Ning Yang, Bin-Chao Wang, Zhen Wang, Ben-Yuan Jiang, Yi-Sheng Huang, Hua-Jun Chen, Zhi Xie, Hong-Xia Tian, Qing Zhou, Chong-Rui Xu, Jian Su, Xu-Chao Zhang, Jin-Ji Yang
PDF file - 253KB, Representative IHC graphs of EGFR, p-EGFR, ALK, p-ALK in EGFR-mutant/ALK-negative, EGFR-WT/ALK-positive tumors, and EGFR-WT/ALK-negative tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b43deb1ee170625da6390299c1445ce7
https://doi.org/10.1158/1078-0432.22448814
https://doi.org/10.1158/1078-0432.22448814
Autor:
Yi-Long Wu, Si-Pei Wu, Ri-Qiang Liao, Li-Xu Yan, Hao-Ran Zhai, Hong-Hong Yan, Jia-Xin Lin, Xue-Ning Yang, Jin-Ji Yang, Qing Zhou, Yue-Li Sun, Hua-Jun Chen, Hai-Yan Tu, Si-Yang Liu, Zhi Xie, Jian Su, Xu-Chao Zhang, Wen-Zhao Zhong, Zhong-Yi Dong
Purpose: Although clinical studies have shown promise for targeting programmed cell death protein-1 (PD-1) and ligand (PD-L1) signaling in non–small cell lung cancer (NSCLC), the factors that predict which subtype patients will be responsive to che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::286a6a87e9257d8b063764d1063b4881
https://doi.org/10.1158/1078-0432.c.6524997
https://doi.org/10.1158/1078-0432.c.6524997